Genomic Health, Inc. (GHDX) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 56
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G4D6551FCDEEN
Leaflet:

Download PDF Leaflet

Genomic Health, Inc. (GHDX) - Medical Equipment - Deals and Alliances Profile
Summary

Genomic Health, Inc. (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in the US, Europe, and Asia through its subsidiaries and offices. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health, Inc. (GHDX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Genomic Health, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deal Details
Venture Financing
InVitae Raises USD120 Million in Series F Venture Financing
Invitae Raises US$40 Million In Series E Financing
Partnerships
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Genomic Health and Epic Sciences Enter into Distribution Agreement
Philips Electronics Enters into Agreement with Genomic Health
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma
Equity Offering
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million
Genomic Health Files Shelf Registration Statement For Public Offering Of US$142 Million
Genomic Health, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 04, 2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results
Feb 10, 2016: Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results
Nov 03, 2015: Genomic Health Reports Highest Test Growth in Two Years in Announcement of Third Quarter 2015 Financial Results
Aug 04, 2015: Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and Prostate Cancer Tests Delivered
May 05, 2015: Genomic Health Announces First Quarter 2015 Financial Results and Reports Record Oncotype DX Test Volume
Feb 10, 2015: Genomic Health Announces Year-End 2014 Financial Results
Product News
Mar 11, 2016: Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX in Node-positive and High-risk Node-negative Breast Cancer
Mar 09, 2016: German National Cancer Guidelines Distinguish Oncotype DX as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence
Mar 01, 2016: Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX
Jan 11, 2016: Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016
Jul 30, 2015: Urology Practice Publishes Study Showing Oncotype DX Increases Use of Active Surveillance in Prostate Cancer Patients by 56 Percent
May 11, 2015: St. Gallen International Breast Cancer Guidelines for the Third Time Distinguish Oncotype DX as the Only Multi-Gene Test Validated to Predict Chemotherapy Benefit
May 07, 2015: Genomic Health to Present Multiple Oncotype DX Studies and Positive Liquid Biopsy Results at American Urological Association Annual Meeting May 15-19
Mar 20, 2015: Multiple Data Presentations Demonstrate Positive Direct Patient Impact of Oncotype DX Breast Cancer Test Globally
Feb 05, 2015: Following NICE's Exclusive Recommendation, NHS England Agrees to Access Program for Oncotype DX Breast Cancer Test
Other Significant Developments
Jan 08, 2016: Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Genomic Health, Inc., Medical Equipment, Key Facts, 2015
Genomic Health, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Genomic Health, Inc., Deals By Market, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
InVitae Raises USD120 Million in Series F Venture Financing
Invitae Raises US$40 Million In Series E Financing
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Genomic Health and Epic Sciences Enter into Distribution Agreement
Philips Electronics Enters into Agreement with Genomic Health
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million
Genomic Health Files Shelf Registration Statement For Public Offering Of US$142 Million
Genomic Health, Inc., Key Competitors
Genomic Health, Inc., Key Employees
Genomic Health, Inc., Other Locations
Genomic Health, Inc., Subsidiaries

LIST OF FIGURES

Genomic Health, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Genomic Health, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Genomic Health, Inc. (GHDX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: